David Carey | Investor Relations |
Jack Peurach | President and Chief Executive Officer |
Max Scheder-Bieschin | Chief Financial Officer |
Stan Fediuk | SunTrust |
Greetings and welcome to the Ekso Bionics’ Fourth Quarter and Full Year 2017 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
For opening remarks, I will now turn the call over to David Carey of Lazar Partners. Thank you, David, you may begin.
Thank you, Devin and thank you all for participating in today’s call.